A new blood test could detect cancer recurrence before scans are capable of picking it up.

New liquid biopsies may reliably detect the recurrence of lung cancer even in its earliest stages, and long before a tumor is large enough to appear on a scan.

That’s according to a study from NYU Langone Health and Grossman School of Medicine, where researchers detailed real-time genetic monitoring which accurately predicted the risk of lung cancer relapse.